Charlottesville, Virginia, United States NeuroVentures is the famous VC, which was founded in 2000. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Charlottesville.
The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2005. The high activity for fund was in 2004. The typical startup value when the investment from NeuroVentures is 5-10 millions dollars. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this NeuroVentures works on 19 percentage points less the average amount of lead investments.
The overall number of key employees were 1.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Biopharma, Neuroscience. Among the various public portfolio startups of the fund, we may underline NeurAxon, BrainCells, Kadmus Pharmaceuticals
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NeuroVentures, startups are often financed by Ventures West, H.I.G. Capital, Oxford Bioscience Partners. The meaningful sponsors for the fund in investment in the same round are Ventures West, Oxford Bioscience Partners, H.I.G. Capital. In the next rounds fund is usually obtained by Ventures West, OrbiMed, New Enterprise Associates.
Related Funds
Funds with similar focus
| Fund Name | Location |
| BlueRock Energy Capital | Houston, Texas, United States |
| BlueSky | Clarksburg, Maryland, United States |
| Chuangshi Ziben | Chengdu, China, Sichuan |
| CICC Xicheng | Beijing, Beijing, China |
| Daylight Entertainment | China, Hengdian, Zhejiang |
| Diamond Edge Ventures | California, San Francisco, United States |
| Dynex Capital | Glen Allen, United States, Virginia |
| i4i-connect | - |
| Innpulsa Colombia | Buenaventura, Colombia, Valle del Cauca |
| JS Capital Management | New York, New York, United States |
| MD Start | France, Ile-de-France, Paris |
| NTT DoCoMo | Chiyoda, Japan |
| OneAngstrom | - |
| Piva Capital | California, San Francisco, United States |
| RIDE ON EXPRESS HOLDINGS Japan | Chiyoda, Japan |
| RK Properties | California, Long Beach, United States |
| Seae Ventures | Boston, Massachusetts, United States |
| Shanghai Puruan Chenhui Venture Capital Center | China, Shanghai |
| Takata Corporation | Auburn Hills, Michigan, United States |
| Yijia Yangguang Shiye Touzi | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BrainCells | $30M | 01 Mar 2008 | San Diego, California, United States | ||
NeurAxon | $32M | 20 Aug 2007 | Ontario | ||
BrainCells | $17M | 15 Jul 2005 | San Diego, California, United States | ||
NeurAxon | $1M | 27 Jul 2004 | Ontario | ||
Kadmus Pharmaceuticals | $15M | 10 Feb 2004 | California, United States | ||
Saegis Pharmaceuticals | $30M | 17 Nov 2003 | California, United States | ||
Cyberkinetics | $9M | 09 Jul 2003 | Massachusetts, United States | ||
Scion Pharmaceuticals | $17M | 15 Jul 2002 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BrainCells | $30M | 01 Mar 2008 | San Diego, California, United States | ||
NeurAxon | $32M | 20 Aug 2007 | Ontario | ||
BrainCells | $17M | 15 Jul 2005 | San Diego, California, United States | ||
NeurAxon | $1M | 27 Jul 2004 | Ontario | ||
Kadmus Pharmaceuticals | $15M | 10 Feb 2004 | California, United States | ||
Saegis Pharmaceuticals | $30M | 17 Nov 2003 | California, United States | ||
Cyberkinetics | $9M | 09 Jul 2003 | Massachusetts, United States | ||
Scion Pharmaceuticals | $17M | 15 Jul 2002 | Boston, Massachusetts, United States |
